Small Molecules for Cancer
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
25
NCT06801002
Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 17, 2025
Completion: Feb 15, 2028
Loading map...